Jpmorgan Chase & Co »

Leap Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1k 267 4.14
2023-09-30 $338 242 1.40
2023-06-30 $711 227 3.13